Search Share Prices
HIK Share Price - Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLC
StockMarketWire.com - Citigroup today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC [LON:HIK] and raised its price target to 2500p (from 2150p).
Hikma wins litigation over heart disease prevention drug
Hikma Pharmaceuticals PLC (LON:HIK) has announced the US Court for the District of Nevada has ruled in its favour regarding a drug to prevent heart disease. The FTSE 100-listed pharma company is ...
Hikma Pharmaceuticals upgraded to ‘overweight’ by JP Morgan after Vascepa litigation win
A US court this week ruled in favour of Hikma, which is developing a generic version of Amarin's Vascepa Hikma Pharmaceuticals PLC (LON:HIK) advanced on Thursday following an upgrade to ‘overweight’ ...
Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLC
StockMarketWire.com - Peel Hunt today upgrades its investment rating on Hikma Pharmaceuticals PLC [LON:HIK] to buy (from hold) and raised its price target to 2380p (from 1990p).